ESMO 2023 Insights: "Vascular Fingerprint Tool to Identify Testicular Cancer Pts at High-Risk for Early Cardiovascular Events After Cisplatin-Based Chemotherapy"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

ESMO 2023 Insights: "Vascular Fingerprint Tool to Identify Testicular Cancer Pts at High-Risk for Early Cardiovascular Events After Cisplatin-Based Chemotherapy"

By Insights from 2023 ESMO Annual Meeting FEATURING Andrea Meuleman

16 views

December 27, 2023

0 Comments

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

Testicular Cancer Highlights From ASCO® GU 2024

Feat. A. Tewari

03:49

UNC Lineberger Comprehensive Cancer Center

UNC Testicular Cancer Management Updates

Feat. H. Tan

30:26

Kenrick Ng

Advances and Unmet Needs in Testicular Cancer: De-Escalating and Div…

Feat. J. Shamash, D. Richardson

16:14

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "2L High-Dose Chemotherapy in Refractory/R…

Feat. E. Waller

15:30

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Germ Cell Tumor Stem Cell Transplantation

Feat. B. Aksoy

18:13

OncoAlert

Treating Genitourinary Cancers With Limited Resources

Feat. Y. Ürün

04:50

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute Testicular Cancer Updates From ASCO GU …

Feat. A. Tewari

13:01

ASCO GU 2023 Conference Coverage

ASCO GU 2023 Interim Analysis of the Prospective Phase II COTRIMS Tr…

Feat. A. Heidenreich

07:47

PrecisCa

GU Tumor Board: 60 y/o Male Presented With Groin Mass and Diagnosed …

Feat. B. Rini, C. Lynn Siegel, C. Shah, J. Abel, A. Drakaki

16:47

Oncology Data Advisor

Personalizing the Approach to Testicular Cancer Management

Feat. A. Bagrodia

07:28

Oncology Data Advisor

Exploring Recent Advances in Testicular Cancer Surgery and Access to…

Feat. A. Winer

13:36

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Hematopoietic Stem Cell Transplantation in Germ Cell Tumors

Feat. A. Mamonova

44:49

40th Anniversary Cisplatin Celebration and Cancer Research Symposium

Platinum and Testicular Cancer: An Oncological Success Story

Feat. L. Einhorn

02:31

Dana-Farber Cancer Institute

Testicular Cancer Highlights From ASCO® GU 2024

Feat. A. Tewari

12:16

ecancer

ASCO® 2023 Summary: "Analysis of Key Studies in Lung Cancer - A…

Feat. L. Raez

03:49

UNC Lineberger Comprehensive Cancer Center

UNC Testicular Cancer Management Updates

Feat. H. Tan

14:20

Insights from 2023 European Multidisciplinary Congress on Urological Cancers

Management of Clinical Stage IIA/B Seminomatous Germ Cell Tumors

Feat. C. Oing

30:26

Kenrick Ng

Advances and Unmet Needs in Testicular Cancer: De-Escalating and Div…

Feat. J. Shamash, D. Richardson

16:14

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "2L High-Dose Chemotherapy in Refractory/R…

Feat. E. Waller

15:30

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Germ Cell Tumor Stem Cell Transplantation

Feat. B. Aksoy

Login

Login

Join VuMedi

ESMO 2023 Insights: "Vascular Fingerprint Tool to Identify Testicular Cancer Pts at High-Risk for Early Cardiovascular Events After Cisplatin-Based Chemotherapy"

Related Content